CELLECT is transforming women's health by addressing the barriers to cervical cancer and HPV screening. Current methods, like Pap smears and swab kits, can be invasive, inaccessible, and costly, especially for women in underserved or remote regions. CELLECT offers a simple, non-invasive alternative through an innovative device embedded in menstrual products. This technology collects and preserves cells and DNA from menstrual blood, making it easy to integrate with existing lab tests. Our solution improves access to life-saving health screenings and has the potential to expand into other reproductive health diagnostics, helping women worldwide receive the care they need.
